New continuous glucose monitor launches in the UK

A new ‘next-generation’ continuous glucose monitor (CGM) by Chinese manufacturing giant Yuwell is now available in the UK.

Launched on Wednesday, May 14, the Yuwell Anytime CGM is set to transform the face of type 2 diabetes, which is one of the biggest drains on the NHS, and the leading cause of serious secondary health complications, such as renal failure, heart disease, stroke and nerve damage.

The new Yuwell Anytime CGM system boasts a world-first rechargeable CGM transmitter that lasts two years, slashing the cost compared to alternative CGM systems.

The cost of the Yuwell Anytime system therefore represents over 35% less per year to both the NHS and self-funding patients, meaning access to life changing tech to combat type 2 diabetes has been revolutionised. 

Add to that the slash in cost to the NHS for treatment and medication through prevention and remission, Yuwell Anytime presents the UK with the opportunity to save the NHS £billions per year and positively improve the health of tens of millions of people.

Yuwell Anytime in the UK will spearhead a national public health campaign for CGM tech to be made more widely available at the grassroots of the type 2 diabetes endemic, to combat the growth of the disease and reduce the number of sufferers. 

Working in partnership with Leeds University, Brunel University and UCL, and with support from the NIHR, Yuwell Anytime will drive prevention and remission. 

Yuwell Anytime Brand Medical Ambassador and NHS GP, Dr Dawn Harper, MBBS, MRCP, DCH, DFFP, said: "I would love to see this device incorporated into the NHS Diabetes Prevention Programme.

“It could help improve the health of millions and save the NHS billions. Having been diagnosed with diabetes myself, wearing the Yuwell anytime device gave me real time insights into how my body reacts to different foods. I used the insights to adapt my diet and my HbA1c is now out of the diabetic range."

Yuwell Anytime Clinical Trial Lead, Dr Andrea Utley, BSc (Hons), PGCE, PhD, said: "Our trial tested the Yuwell Anytime device on a diverse range of individuals with type 2 diabetes. 

“Findings showed a good level of accuracy when compared to a standard finger prick glucose test.”

She added: “In addition the Yuwell device proved to trend well showing excellent performance across a range of glucose levels.”